Home › Myasthenia Gravis › Florida
Myasthenia Gravis clinical trials in Florida
20 studies for Myasthenia Gravis are looking for participants at sites in Florida.
Cities in Florida
- Tampa11 studies
- Boca Raton8 studies
- Miami6 studies
- Jacksonville5 studies
- Port Charlotte4 studies
- Orlando4 studies
- Clearwater3 studies
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1006, Clearwater
- Site Number - 1008, Miami
- Site Number - 1037, Ormond Beach
- and 3 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- FM Clinical Research, LLC South Florida Neurology Associates, P. A., Boca Raton
- Medsol Clinical Research Center Inc, Port Charlotte
- University of South Florida, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT04951622A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- University of South Florida Morsani Center for Advanced Healthcare, Tampa
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Nov 4, 2026 · NCT05265273ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Visionary Investigators Network, Miami
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07673627Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- SFM Clinical Research LLC, Boca Raton
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Nov 3, 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Boca Raton
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 30, 2026 · NCT07647510A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, Clearwater
- TG Therapeutics Investigational Trial Site, Maitland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07673744ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Visionary Investigators Network, Miami
- Visionary Investigators Network, Miami
- University of South Florida, Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07294170Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- Moffitt Cancer Center, Tampa
- University of South Florida - Carol and Frank Morsani Center for Advanced Healthcare, Tampa
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06626919Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Neurology of Central Florida Research Center, LLC, Altamonte Springs
- SFM Clinical Research, LLC, Boca Raton
- University of Florida Health Science Center - 300120311, Jacksonville
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06463587RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Mayo Clinic Florida, Jacksonville
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06359041ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Visionary Investigators Network, Miami
- University of South Florida, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07284420Zilucoplan for Severe gMG Exacerbations
- University of South Florida/Tampa General Hospital, Tampa
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- SFM Clinical Research, LLC, Boca Raton
- Neuromuscular Research Division | University of South Florida, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06414954Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Altamonte Springs
- Aurinia Investigational Site, Boca Raton
- Aurinia Investigational Site, Homestead
- and 2 more
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Aug 3, 2026 · NCT07596901KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- University of Miami, Miami
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Clearwater
- Clincal Trial Site, Gainesville
- Clinical Trial Site, Jacksonville
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- SFM Clinical Research, LLC, Boca Raton
- University of Florida College of Medicine Jacksonville, Jacksonville Beach
- Medsol Clinical Research Center Inc, Port Charlotte
- and 1 more
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Neurology of Central Florida Research Center, LLC, Altamonte Springs
- SFM Clinical Research, LLC, Boca Raton
- Aqualane Clinical Research, Naples
- and 2 more
RecruitingPhase 1/2
Ages 18 to 74 · All sexes · Updated Feb 11, 2026 · NCT07250750The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- University of Florida Health, Jacksonville
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 11, 2025 · NCT05564936From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.